Results 131 to 140 of about 8,310 (238)
RWE AG Geschaeftsbericht 1989/90
SIGLECopy held by FIZ Karlsruhe; available from UB/TIB Hannover / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische ...
Rheinisch-Westfaelisches Elektrizitaetswerk A.G. (RWE), Essen (Germany)
core
ABSTRACT Quantitative medicine supports modern drug development and regulatory decision‐making by integrating non‐clinical and clinical data to inform dose selection, trial optimization, and extrapolation across populations and benefit–risk assessment.
Essam Kerwash +3 more
wiley +1 more source
Plain language summary: What is this article about? This article discusses the challenges of using non local real-world evidence (RWE) in health technology assessments (HTA) when local data are unavailable, insufficient, or inappropriate.
Caitlin Clunie-O’Connor +6 more
doaj +1 more source
ABSTRACT Aims This study evaluated long‐term cost‐effectiveness of automated insulin delivery (AID) systems versus multiple daily injections (MDI) + CGM in children with type 1 diabetes (T1D), adults with T1D and insulin‐treated individuals with type 2 diabetes (T2D) across Denmark, Finland, Norway and Sweden.
Johan Jendle +5 more
wiley +1 more source
RWE Aktiengesellschaft. Geschaeftsbericht 1991/92
Copy held by FIZ Karlsruhe; available from UB/TIB Hannover / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische ...
Rheinisch-Westfaelisches Elektrizitaetswerk A.G. (RWE), Essen (Germany)
core
The goal of this bachelor thesis is a fundamental analysis of the company RWE. The first part examines the impact of macroeconomic variables on the stock price.
Kocourek, Ivan
core
RWE AG. Geschaeftsbericht 1990/91
Available from FIZ Karlsruhe / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische ...
Rheinisch-Westfaelisches Elektrizitaetswerk A.G. (RWE), Essen (Germany)
core
Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies. [PDF]
Blandy O +5 more
europepmc +1 more source
What the future holds: the growing role of real-world evidence in health technology assessment in Malaysia. [PDF]
Lim JS, Lee KKC.
europepmc +1 more source
Aim: Regulatory and health technology assessment (HTA) agencies have increasingly published frameworks, guidelines, and recommendations for the use of real-world evidence (RWE) in healthcare decision-making. Variations in the scope and content of these
Grammati Sarri, Luis G Hernandez
doaj +1 more source

